Login

Unlocking the potential of your asset management business.|Mathias Österberg, CEO, GRIT Governance 00:10:00

Share On Facebook Share On Twitter

Mathias Österberg is the CEO of GRIT Governance.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Q2 2022 Financial Insights & Strategies
00:10:00
Understanding Transaction Types: Mike Lyon Explains Minority, Majority, and Full Sale Options for Business Owners | Mike Lyon – Founder and Managing Director, Vista Point Advisors
00:10:00
Heikki Haasmaa on the Importance of Diverse Perspectives in Designing Future Smart Cities | Heikki Haasmaa, CEO, Sitowise Group Oyj.
00:10:00
Schizophrenia Assessment: Monitoring Symptoms, Treatment, and Side Effects
00:10:00
One Powerful Relationship,Boundless Opportunities|Stephen Dover|Chief Market Strategist, Head of Franklin Templeton Institute,Franklin Templeton Institute
00:10:00
Deepinder Goyal on Zomato's 15-Year Growth and Profitability | Deepinder Goyal, CEO , Zomato Ltd.
00:10:00
Pioneering Economic Resilience and Financial Opportunities | Dato’ Seri Cheah Cheng Hye, Co-Chairman , Value Partners .
00:10:00
Bittium Q2 8.8.19 | Hannu Huttunen, CEO, Bittium OyjBITTI:HEX
00:10:00
Investing for retirement made easier | Ron Peyton,CEO and executive chairman, CIT Callan International Equity Fund
00:10:00
Navigating Market Trends: Genova Property Group’s Interim Report for 2023 | Michael Moschewitz ,CEO , Genova Property Group AB.
00:10:00
Crafting Your Financial Future | Smith Bruer Advisors
00:10:00
conversations and now we are sharing them with you every month|Ari Newman,Partner, The Fund Rockies,The Fund

© 2026 Nehu